Matthew W Foehr insider trades
Open-market stock purchases and sales by Matthew W Foehr, President and CEO at OmniAb, Inc, from SEC Form 4 filings since Apr 18, 2011.
Track record: 75% of 12 scored buys are up 5% or more since purchase, averaging +56%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 7, 2026 | OABI OmniAb, Inc | Sold | $28.7K |
| Apr 7, 2026 | OABI OmniAb, Inc | Bought (not open market) | — |
| Feb 18, 2026 | OABI OmniAb, Inc | Sold | $52.7K |
| Feb 18, 2026 | OABI OmniAb, Inc | Bought (not open market) | — |
| Feb 18, 2026 | OABI OmniAb, Inc | Bought (not open market) | — |
| Feb 18, 2026 | OABI OmniAb, Inc | Bought (not open market) | — |
| Feb 17, 2026 | OABI OmniAb, Inc | Sold | $35.3K |
| Feb 16, 2026 | OABI OmniAb, Inc | Bought (not open market) | — |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc | Sold | $562K |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc | Bought (not open market) | — |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc | Bought (not open market) | — |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc | Bought (not open market) | — |
| Dec 8, 2025 | OABI OmniAb, Inc | Sold | $26.8K |
| Dec 7, 2025 | OABI OmniAb, Inc | Bought (not open market) | — |
Companies traded
- OABI OmniAb, Inc: 10 buys, 9 sales, last Apr 7, 2026
- VKTX Viking Therapeutics, Inc: 5 buys, 2 sales, last Jan 2, 2026
- LGND Ligand Pharmaceuticals Inc: 7 buys, 22 sales, last Nov 1, 2022
- RTTR Ritter Pharmaceuticals Inc: 7 buys, last Apr 10, 2020
- LGNDD Ligand Pharmaceuticals Inc: other filings, last Feb 9, 2012